首页 >
法规速递
-
Page: CHMP opinions on consultation procedures-2025/12/4
2025-12-05查看详情 > -
Document: Consultation on an ancillary medicinal substance incorporated in a medical device - Gynemed GmbH & Co. KG HSA-containing ART media-2025/12/4
2025-12-05查看详情 > -
Document: Consideration on core requirements for RMPs of COVID-19 vaccines-2025/12/4
2025-12-05查看详情 > -
Page: Availability of medicines before and during crises-2025/12/4
2025-12-05查看详情 > -
Document: Agenda - HMA/EMA Annual Data Forum 2025-2025/12/4
2025-12-05查看详情 > -
Page: Antiviral medicines for pandemic influenza-2025/12/4
2025-12-05查看详情 > -
Page: Signal management (veterinary medicines)-2025/12/4
2025-12-05查看详情 > -
Page: Veterinary good pharmacovigilance practices (VGVP)-2025/12/4
2025-12-05查看详情 > -
Document: Veterinary Union Pharmacovigilance Database - Best Practice Guide-2025/12/4
2025-12-05查看详情 > -
Document: Veterinary signal assessment report for marketing authorisation holders-2025/12/4
2025-12-05查看详情 >
